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It has been found with relative con- 
sistency in Western aas well as non- 
Western populations 2 that a youn- 
ger age at menarche, older age at 
first birth, and older age at meno- 
pause conferred a higher risk of 
breast cancer. Biological bases of 
these associations, including the 
effects of estrogens and gestagens 
on cell proliferation, have now been 
thoroughly investigated 3. 
There is, however, important vari- 
ability in these associations across 
populations. An international study 
showed that younger age at men- 
arche was associated with increas- 
ed risk of breast cancer in Japan 
and Taiwan, countries with a late 
mean age at menarche (14.6 years 
in cases and 14.8 years in controls), 
but was not related to breast cancer 
risk in Brazil, Greece, Yugoslavia, 
Wales and the U.S., where the 
mean ages at menarche were about 
one year younger than in Japan 
and Taiwan 4. Similarly, the strength 
of the association between age at 
first birth and breast cancer risk 
has varied considerably across stu- 
dies 5. Weaker associations have 
been observed in populations where 
a first birth before age 20 is rela- 
tively uncommon. In the collabora- 
tive study conducted in Greece, 
U.S., U.K., Japan, Taiwan, Brazil, 
and Slovenia, a first pregnancy 
before the age of 18 was associated 
with a two-thirds reduction in risk 
compared to a first pregnancy over 
the age of 356. In contrast, in a 
recta-analysis of eight studies from 
the Nordic European countries, 
women with a first birth before the 
age of 20 years had only a 40% 
decrease in risk compared to those 
with a first birth after the age of 
35 years 1. These international stu- 
dies are not necessarily consistent 
with all epidemiologic studies con- 
ducted in the particular countries, 
but the point here is that the re- 
lative homogeneity of reproductive 
histories within specific popula- 
tions may negatively affect statis- 
tical power and explain at least in 
247 
part the inconsistent findings across 
individual-level studies. 
One way to address the lack of 
variability of exposure and of risk 
usually found in single populations 
is to compare different populations 
across the world and to correlate 
average population characteristics 
with incidence or mortality of a 
given disease 7,8. For example, in the 
collaborative study conducted in 
Greece, U. S., U. K., Japan, Taiwan, 
Brazil, and Slovenia, age at first 
birth ranged from 15 to 40 years 6, 
which is unusual for most Western 
countries 9,1~ International ecolo- 
gical study designs cannot resolve 
problems related to lack of variabi- 
lity of exposure or of risk - indeed, 
only comparisons of individual- 
level data across different popula- 
tions could ultimately serve that 
purpose. However, international 
ecologic studies can serve to aug- 
ment insights into associations 
observed in individual level stu- 
dies 11 of the relationship between 
breast cancer and reproductive 
history. 
In this study we present he cor- 
relations between the incidence of 
breast cancer reported by tumor 
registries in seven different loca- 
tions of the world and the timing 
of reproductive vents based on 
samples of women from popula- 
tions belonging to these countries. 
The diverse study populations serve 
to indicate the whole range of 
observable variability in the world 
population. 
Subjects and methods 
Study women 
The study sample consisted of 9416 
of the 18997 women comprising 
the control group in a World 
Health Organization (WHO) inter- 
national multi-center case-control 
study of female cancers, descrip- 
tions of which and primary results 
therefrom have been previously 
reported based on data collected 
from 1979 to 1986 by the WHO 
Collaborative Study of Neoplasia 
and Steroid Contraceptives 12-15. 
Analyses for the present report 
were based on a subset of the data 
from those control women plus 
further data collected on additional 
control women for the WHO study 
as subject recruitment continued 
through 1988. Of the 13 popula- 
tions in 11 different countries that 
were part of the original WHO 
study, we included in the present 
report only the seven populations 
which had corresponding tumor 
registry data on breast cancer in- 
cidence available in existing pub- 
lished sources (Australia, People's 
Republic of China, Colombia, (for- 
mer) German Democratic Repub- 
lic, Israel, Philippines, and one 
region in Thailand). The latest in- 
cidence data available for Nigeria 
were too old (1960-1969). 
The WHO study control group 
consisted of women who had been 
admitted to other than obstetrics- 
gynecology hospital wards and who 
were free of medical conditions 
possibly thought to alter contra- 
ceptive practices (i.e., cardiovas- 
cular and circulatory diseases, dia- 
betes, chronic renal disease, benign 
breast disease, cancer, chronic liver 
disease, and any obstetrical or gyn- 
ecological condition) (see Table 2 
in reference 13). These women were 
selected from a large variety of dif- 
ferent clinics within each sampled 
region in order to avoid any link 
between their reproductive char- 
acteristics and their likelihood of 
being recruited into the WHO 
study. The control women were of 
the same age and residential origin 
as the cases. These hospital control 
patients were interviewed, mostly 
in the hospital, between 1979 and 
1988 using a standardized ques- 
tionnaire administered by trained 
female interviewers. 
Breast cancer incidence data 
Breast cancer incidence rates (per 
100000 women per year) for the 
seven study populations were ab- 
stracted from Volume VI of Can- 
cer Incidence in Five Continents 16. 
World age-standardized (i.e., using 
the world population as reference) 
rates were employed. 
Reproductive variables, statistical 
analyses, and sample sizes 
The five main study variables 
(measured in years) used to assess 
the reproductive histories of the 
sample women from each study 
population were age at menarche, 
delay from menarche to first (live) 
birth, age at first (live) birth, age at 
(natural) menopause, and duration 
of reproductive life (time between 
menarche and (natural) meno- 
pause). For each of the seven study 
populations we summarized the 
distributions of the reproductive 
variables using the median (P50 = 
50 th percentile) and other percen- 
tiles ((P10, P25, P75, P90) for age 
at menarche; (P10, P25, P75) for 
delay to and age at first birth; (P10, 
P25) for age at menopause and 
duration of reproductive life). The 
ecological relationships between 
the breast cancer incidence rates 
and the median (or other percen- 
tile) of each reproductive variable 
across the seven study populations 
were studied using bivariate scat- 
terplots, least squares regression 
lines, and Pearson simple and 
median age-adjusted partial cor- 
relation coefficients. To assess po- 
tential generation effects the ecol- 
ogic analyses for each reproductive 
variable were repeated separately 
for study women in the four age-at- 
interview subgroups 15-29, 30-39, 
40-49, 50-64 years within each 
population. 
Age at menarche 
Age at menarche was directly re- 
ported by the study women during 
their interview. In the analyses of 
this (and of all the other) reproduc- 
tive variables, 20 women who ei- 
ther reported never menstruating 
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or whose menstruation status or 
age at menarche were recorded as 
unknown were excluded (net total 
N --- 9396). 
Age at menopause and duration 
of reproductive life 
Most of the study women had not 
yet experienced menopause ( ither 
natural or artificial) by the time 
they were interviewed. Thus, we 
used Kaplan-Meier survival analy- 
sis methodology 17 to construct the 
sample distributions of age at 
menopause and of duration of re- 
productive life (= age at meno- 
pause age at menarche) for each 
population, from which the cor- 
responding medians and other per- 
centiles were estimated. 
These Kaplan-Meier analyses re- 
quired information on menopausal 
status (i. e., censoring) which was 
not directly reported during the 
interview. We therefore calculated 
this information indirectly using a 
classification algorithm applied to 
year of last menses, year of inter- 
view, year of birth (derived from 
age), and other relevant reproduc- 
tive data (see below) that were 
directly reported during the inter- 
view. The logic and results of this 
classification algorithm are sum- 
marized briefly below. 
For all menarchal study women, 
age at menopause was initially cal- 
culated as (year of last menses -
year of birth), regardless of censor- 
ing. Study women who were actual- 
ly classified as having undergone 
natural menopause (total N = 1936) 
were at least required to have had 
their last reported menses more 
than one year before their year of 
interview. Study women who had 
undergone ither a hysterectomy, a 
double oophorectomy, or any ope- 
ration/x-ray treatments preventing 
further menstrual periods at any 
time before or during their year of 
interview were classified as having 
had an artificial menopause (total 
N = 642), and their initially calculat- 
ed age at menopause was consid- 
ered to be censored at the year 
of artificial menopause. For pre- 
menopausal (including a few preg- 
nant and/or nursing) study women 
(total N = 6789), their initially 
calculated age at menopause was 
considered to be censored at the 
year of their interview. Study 
women for whom any of the algo- 
rithm calculations involved mis- 
sing data were classified as missing 
menopausal status (missing total 
N = 49). 
The resulting sample sizes for age 
at menopause (net total N = 9361) 
and duration of reproductive life 
(net total N = 9360) reflected the 
exclusions due to missing meno- 
pausal status (with 41% of these 
due to age at menarche, as noted 
above), as well as a few additional 
exclusions due to missing data on 
age and/or some of the other repro- 
ductive variables (e. g., year of last 
menses, hysterectomy status, etc.) 
used to calculate menopausal status. 
The study women from East Ger- 
many ((former) German Demo- 
cratic Republic) were not quite old 
enough to estimate their median 
age at menopause. Instead, because 
the estimated 49.3 rd percentile for 
this population was 51 years, we 
conservatively estimated the me- 
dian age at menopause for the 
German Democratic Republic as 
52 years. 
Likewise, the study women from 
Israel were not old enough to esti- 
mate their median age at meno- 
pause and their median duration 
of reproductive life. However, the 
respective sample 38.1 st and 44.2 nd 
(the last estimable) percentiles for 
the latter two variables were 51 
and 40 years. Thus, we conserva- 
tively estimated the median age at 
menopause as 52 years and the 
median duration of reproductive 
life as 41 years for Israel. 
Age at first birth and delay from 
menarche to first birth 
The vast majority (9411/9416) of 
the study women provided non- 
missing interview data on age at 
first birth. Most (7806/9411), but 
not all, of these women reported 
actually having had a live birth. 
Each of the 1605 nulliparous 
women had a censored age at first 
birth (hence also a censored elay 
from menarche to first birth) taken 
as: her age at natural menopause if 
she had experienced a natural 
menopause; her age at artificial 
menopause if she had undergone 
an artificial menopause; and just 
her age if she was still pre-meno- 
pausal. Likewise, the censored 
delay from menarche to first birth 
for nulliparous study women was 
calculated as the difference be- 
tween their censored age at first 
birth and their age at menarche. 
Kaplan-Meier methodology anal- 
ogous to that described in the pre- 
vious section was then employed 
to estimate the distributions and 
percentiles of age at first birth 
and delay from menarche to first 
birth. 
The resulting sample sizes for age 
at first birth (net total N = 9385) 
and delay from menarche to first 
birth (net total N = 9383) reflect- 
ed slight reductions for reasons 
similar to those mentioned in the 
previous section. The reductions 
were less extreme here than there 
because missing values for me- 
nopausal status necessarily led to 
exclusions only for nulliparous 
women. Multiparous women with 
valid ages at first birth were not 
necessarily excluded if they had 
missing data on menopausal sta- 
tus. 
Results 
The breast cancer incidence rates 
in the seven study countries, to- 
gether with the specific popula- 
tions and the years of tumor regis- 
try coverage are given in Table 1. 
There was a five-fold ratio be- 
tween the highest (64.7/100000/yr) 
and the lowest (13.7) breast can- 
cer incidence rates. The highest 
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Table I. World age-standardized breast cancer incidence rates I (per 
100 000 women per year), specific populations and years of registry cover- 
age corresponding to the seven WHO study locations, ordered by decreas- 
ing incidence rates. 
breast cancer incidence rates were 
observed in the more Western 
(Israel and Australia) countries, 
and the lowest rates in the Asian 
(Thailand and China) countries. 
The interview years, sample sizes, 
and summaries of the age distribu- 
tions for each of the WHO study 
samples are given in Table 2. The 
study women were relatively oung 
Table 2. Interview years, sample sizes, and age distributions (years) in the 
seven WHO study samples. 
(total age range 15-64 years). 
There was reasonable concordance 
between the years of tumor regis- 
tration (1982-1987) and the inter- 
view periods of the WHO study 
(1979-1988), and also between the 
populations covered by the tumor 
registries and those that were 
sampled in the WHO study (see 
data collection centers in Ap- 
pendix). 
Summaries of the distributions of 
the five reproductive variables 
are given in Table 3. Because the 
study women were so young (see 
Table 2), the 90 th percentiles for 
age at and delay to first birth could 
be estimated for only half of 
the study populations (data not 
shown). Likewise, the 75 th (90 th) 
percentiles for age at menopause 
and duration of reproductive life 
could be estimated for only two 
of the study populations (data not 
shown). 
The breast cancer incidence rates 
(see Table 1) are also presented 
graphically in the upper left panel 
of Figure 1. The other scatterplots 
in Figure 1 depict he relationships 
between breast cancer incidence 
and the medians of the five repro- 
ductive variables in Table 3. Similar 
rankings among the countries as 
seen in Table 1 can be observed on 
most of the axes for each of the five 
reproductive variables in Figure 1. 
For example, Thailand always be- 
longs to the group with older age 
at menarche, younger age at first 
birth, and shorter delay to first 
birth. Thailand has in addition a 
younger age at menopause and a 
shorter duration of reproductive 
life. People's Republic of China 
behaves as a low-risk country for 
the two physiologically determined 
variables (age at menarche and age 
at menopause) but as a westernized 
country for the culturally deter- 
mined variables (age at and delay 
to first birth). 
The Pearson simple and (median) 
age-adjusted correlations between 
the breast cancer incidence rates 
and the medians of each of the five 
250 
S0z.- Praventivmed. 200:0; 45:247.257 
Delay to Age at Age at 
first birth b first birth b menopause c 
14.~5) 9 (5, 7, 13) 22 (18. 20, 26) 52 d (46, 49) 41 e (32, 36):: 
14,15) 11 (5,8, 16) 24(18,21,29) 51 (45,48) 38 (31,35) 
15. 16) 10 (3, 6, 16) 23 (t7, 20, 30) 50 (44, 47) 37 (30,33) 
t5. 16) g/c4; 6, 13) 22 (18, 20, 26) 52 ~ (46, 49) 38 (32, 35) 
14, 15) 7(3,4, 11) 20(16, 18,24) 50 (41,47) 36 (2&,34) 
16, 17) .... 10(4, 7, 13) 25(20, 23,28) 49 (45,47) 34 (29,32) 
17, 18) 6 (2, 3, 10) 22 (18, 20, 26) 49 (40, 45) 32 (24, 28) 
percentile. 
s = 44.2 ~d percentile. 
i ra percentile, 
Table 3. Medians (percentiles) of reproductive variables (years) in the seven WHO study samples. 
>- 
8 
o 
8 
8 
8 
8 
o 
ISR AUS PHL GDR COL PRC CMT 
8 
1,18~ 
13.0 14,0 15.0 16.0 
AGEATMENARCHE 
8 
IBR . 
AU8 9 
GDR 
PRC 9 
9 CMT 
B 7 8 9 'i0 11 
DELAY TO FIRST BIRTH 
U m 
g 
8 
o 
ISR 9 
9 AUS 
GDR 9 9 PHL 
9 COL 
CMT 9 
20 21 22 
PRC 9 
23 24 25 
8 
m 
8 
8 
8 
o 
ISR 9 
9 PHL . .~ GDR 9 
CMT 
49.0 50.0 51.0 52.0 
== 
8 >= AU8 , ~  
32 34 36 3B 40 
AGE AT FIRST BIRTH AGEATMENOPAUSE DURATION OF REPRODUCTIVE LiFE 
Figure 1. World age-standardized breast cancer incidence per 100000 women per year (BC/ 7 OOOOO/yr) (barplot) 
and relationships between BC/lOOOOO/yr and medians (50th percentiles) of reproductive variables (scatterplots 
with least squares regression lines) in seven WHO study locations. 
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Table 4. Pearson simple correlations (r) and median age-adjusted partial 
correlations (partial r) between world age-standardized breast cancer in- 
cidence rates and the medians (50th percentiles) of reproductive variables 
for the seven WHO study samples. (Simple r's correspond to the regression 
lines in Figure 1.) 
reproductive ariables corresponding 
to the scatterplots and least squares 
regression lines in Figure i are 
given in Table 4. Strong positive 
associations with breast cancer in- 
cidence were observed for dura- 
tion of reproductive life (r = 0.95, 
p = 0.004 with age-adjustment) and 
age at menopause (r = 0.87, p = 
0.023 with age-adjustment). Con- 
versely, a strong inverse correla- 
tion was observed between age at 
menarche and breast cancer in- 
cidence (r = -0.87, p -- 0.025 with 
age-adjustment). Age at first birth 
was not associated with breast 
cancer incidence (r = 0.18, p = 0.73 
with age-adjustment). Delay to first 
birth was moderately positively 
(but not significantly) associated 
with breast cancer incidence (r = 
0.59, p = 0.22 with age-adjustment). 
People's Republic of China was 
an influential point in the latter 
correlations. When People's Re- 
public of China was omitted, the 
simple and partial correlations 
between age at first birth and 
breast cancer incidence increased 
to r = 0.44 and 0.58, respectively, 
but neither was statistically signifi- 
cant (respective p = 0.38 and 0.30). 
Table 5. Pearson correlations (simple r) and median age-adjusted partial 
correlations (partial r) between the world age-standardized breast cancer 
incidence rates and the 25th percentiles of reproductive variables for the 
seven WHO study samples. 
On the other hand, the simple and 
partial correlations between delay 
to first birth and breast cancer in- 
cidence increased to r = 0.86 and 
0.85, respectively, the first of which 
was statistically significant (p = 
0.029) and the second of which 
was not quite statistically signifi- 
cant (p -- 0.069). 
Similar qualitative patterns and 
magnitudes of associations be- 
tween the breast cancer incidence 
rates and the 10 th and 25 th percen- 
tiles, and (when estimable) the 75 th 
and 90 th percentiles, of the repro- 
ductive variables were also observ- 
ed. The simple and partial correla- 
tion results for the 25 th percentiles 
(only), which could be estimated 
for all countries, are shown in 
Table 5. As occurred for the me- 
dians, omitting People's Republic 
of China from the calculations 
led to non-statistically significant 
increases in the correlations of 
breast cancer incidence with age at 
and delay to first birth (data not 
otherwise shown). 
The more culturally determined 
age at and delay to first birth were 
the only reproductive variables 
for which generation effects could 
be discerned (data not shown ex- 
cept as noted below). Specifically, 
for most of the populations we 
found that the study women in the 
two youngest (15-29 and 30-39 
years) age subgroups tended to 
be older at (correspondingly, to 
delay slightly longer until) their 
first birth compared to the study 
women in the two older (40-49 
and 50-64 years) age subgroups 
(see1~ 
Potential generation effects rela- 
tive to the overall association be- 
tween the breast cancer incidence 
rates and the median ages at first 
birth (see Figure i and Table 4) 
were assessed by examining the 
scatterplots with least squares 
regression lines and the simple 
correlations between these two 
variables within each age subgroup 
shown in Figure 2. The association 
was weakly positive in each of the 
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Figure 2, Non-significant (all p > 0.60) correlations between world age- 
standardized breast cancer incidence per 100 000 per year (BC/I O0 O00/yr) 
and median age at first five birth in seven WHO study locations stratified by 
age subgroups. 
age subgroups 40-49 and 50-64 
years (r = 0.24 and 0.19, respective- 
ly), but was weakly negative in the 
age subgroups 15-29 and 30-39 
years (r= -0.14 and-0.06). How- 
ever, as indicated, none of these 
correlations were statistically signi- 
ficant (all p > 0.60). As above, 
People's Republic of China was an 
influential point in the latter cor- 
relations. When People's Republic 
of China was omitted, the correla- 
tions in the 15-29, 30-39, 40-49 
and 50-64 years subgroups were 
all positive (r = 0.24, 0.68, 0.59 
and 0.38, respectively). However 
again, none reached statistical sig- 
nificance (respective p = 0.65, 0.13, 
0.22, 0.46). 
Discussion 
This international ecological study 
shows strong correlations of breast 
cancer incidence with age at men- 
arche, duration of reproductive 
life, age at menopause, and (when 
People's Republic of China is omit- 
ted) delay to first birth. For these 
factors, the ecological study agreed 
with what has been observed in 
individual-level studies. 
On the other hand, the association 
of breast cancer incidence with age 
at first birth (including omission of 
People's Republic of China and 
allowance for generation effects) 
was much weaker than expected 
from individual-level studies. The 
correlation was strongly influenced 
by the atypical behavior of People's 
Republic of China, which had a low 
incidence of breast cancer but a 
late age at first birth. The Chinese 
policy towards wedding age and 
parity may have had some influen- 
ce on the corresponding incidence 
of breast cancer. The higher age at 
first birth may explain in part 
why higher rates of breast cancer 
were observed in People's Repub- 
lic of China compared to Thailand. 
However, such changes in repro- 
ductive life may not yet have been 
followed by full changes in inci- 
dence. There is a time lag that is 
not accounted for in this study. 
These results may also indicate that 
it is not so much the specific age at 
first birth, but the delay between 
menarche and first birth that con- 
fers the increased breast cancer 
risk. Russo et al.lS have suggested 
that the susceptibility of the mam- 
mary gland to carcinogens may be 
the highest during the years be- 
tween menarche and first birth, i.e., 
when the glandular epithelium has 
not yet been fully differentiated. 
If so, the longer the delay to first 
birth, the higher the risk, irrespec- 
tive of the specific age at menarche 
or age at first birth. This interpre- 
tation contradicts however other 
results howing that age at first birth 
and age at menarche are indepen- 
dent risk factors for breast cancer. 
For example, Henderson et al. 19 
found that the odds ratio (OR) for 
breast cancer was 1.58 for men- 
arche < 13 years, 1.75 for first deli- 
very at 2_ 25 years, and 2.76 for 
(menarche <13 & first delivery at 
2 25). Thus, the observed OR for 
the joint effect corresponds to the 
OR expected under simple multi- 
plicativity (2.78 (1.58 x 1.75). 
Limitations and strengths 
We compared reproductive his- 
tories obtained from individual 
women controls participating in an 
international case-control study 
with breast cancer incidence data 
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derived from country-specific cancer 
registries that did not cover the 
exact same target populations. We 
employed censored data analysis 
techniques to estimate the per- 
centiles of age at and delay to first 
birth, age at menopause, and dura- 
tion of reproductive life because 
the study women were relatively 
young. The percentiles estimated 
from the individual-level data were, 
of course, aggregated measures, o 
the study design and the correla- 
tions were really fully ecological. 
Because only seven (six with 
omission of People's Republic of 
China) countries were included 
and because relevant covariate in- 
formation was unavailable in the 
source data, we could not effective- 
ly adjust the correlations for dif- 
ferences among the countries on 
the reproductive or other variables 
(e.g., dietary factors) that are 
potentially confounded with or re- 
lated to breast cancer incidence. 
These are clear limitations of our 
ecologic study in comparison 
with traditional individual-level 20-23 
(also with hybrid "aggregate data" 
multilevel 24 or other 2s analytic) 
case-control r cohort studies. 
Furthermore, selection bias may 
also have been a problem because 
the study sample women were hos- 
pital controls and access to hospital 
care may be more frequent for 
women of higher socio-economic 
status than for other women. 
Women who are more well-off are 
more likely to live in urban areas 
and their way of life may more 
closely resemble that of Western 
women. On the other hand, women 
with diseases thought to alter 
contraceptive practices were not 
eligible since these were originally 
controls of a case-control study 
on steroid contraceptive usage a2-15. 
Also, life habits related to ages of 
reproductive events (e. g., smoking, 
diet, drinking) of women hospital- 
ized may differ from the rest of the 
population. The net bias resulting 
from these multiple potential sour- 
ces of selection on international 
variability remains unpredictable 
from the secondary analyses per- 
formed here because the specific 
data required to measure it were 
not collected in the original case- 
control study. 
International ecological study cor- 
relations may involve a different 
construct rarely taken into account 
by individual-level associations .
In the present context, our (ag- 
gregated) ecological measure, "age 
at first birth", may represent dif- 
ferent etiological aspects relative 
to breast cancer than the "age at 
first birth" of an individual woman. 
Breast cancer is a disease with a 
complex etiology. Many of its iden- 
tified or postulated causes, such 
as timing of reproductive vents, 
body mass or diet, seem to be relat- 
ed to westernization. As a result, 
an ecological design which uses 
populations as the units of analysis 
may be able to assess the full 
impact of processes affecting pop- 
ulations as a whole rather than 
subgroups within each population. 
Indeed, in the WHO Collaborative 
Study of Neoplasia and Steroid 
Contraceptives 14,the risk of breast 
cancer was found to increase with 
later age at first birth and later age 
at menopause, but was not related 
to age at menarche. Thus, age at 
first birth was an important risk 
factor for breast cancer in the indi- 
vidual-level case-control analysis 
but not an important discriminator 
of breast cancer incidence across 
populations. Age at first birth may 
be modified early in the process 
of westernization and therefore 
reaches international homogeneity 
faster than the breast cancer risk. 
As a result, we observe similar 
age at first birth in countries with 
different age-standardized breast 
cancer incidence. 
This hypothesis i apparently sup- 
ported by the present results which 
show a generation effect on the 
overall association between age at 
first birth and breast cancer in- 
cidence. Although none of the 
correlations were statistically signi- 
ficant, the association was weakly 
positive in the subgroups of study 
women beyond age 39 years, and 
weakly negative in the age sub- 
groups 15-29 and 30-39 years. 
(However, as mentioned, all four 
correlations became (nonsignifi- 
cantly) positive when People's Re- 
public of China was omitted.) The 
youngest age subgroup also had the 
highest median age at first birth. 
Homogeneity of age at menarche 
within populations, but variations 
among populations, would yield no 
association in case-control studies, 
but would yield an association in 
ecological studies. Doubtless, the 
epidemiological "gold standard" 
for establishing etiologic associa- 
tions is an individual-level study 
(perhaps augmented by measuring 
and incorporating ecologic variables 
through a multilevel analysis). 
Several elements peak in favor of 
the validity of the present findings 
relative to bias. First, the infor- 
mation on reproductive histories 
obtained in the WHO study was 
collected uniformly by trained 
female interviewers using the same 
questionnaire and methodology. 
And second, most of the observed 
correlations were quite strong. 
In conclusion, the international 
ecological correlations observed in 
this study are in agreement with 
current beliefs regarding the asso- 
ciations of the reproductive factors 
age at menarche, age at meno- 
pause, duration of reproductive life 
and, possibly, delay to first birth 
with breast cancer incidence deriv- 
ed from epidemiological studies 
based on individual-level data. 
Thus, it appears that these repro- 
ductive factors represent similar 
constructs when measured on the 
ecologic and individual evels. The 
disagreement relative to the as- 
sociation of age first birth with 
breast cancer incidence observed 
in individual-level studies versus 
the lack of association observed in 
the present ecologic study is not 
sufficient to question or discount 
the former finding. Rather, it serves 
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to indicate that "age at first 
birth" represents different con- 
structs depending on whether it is 
measured on an ecologic or in- 
dividual level. Resolut ion of this 
discrepancy can only be achieved 
through the development of indi- 
vidual-level study designs which 
additionally measure and incor- 
porate individual- and supra-indi- 
vidual level variables through mul- 
tilevel analyses. 
zwischen Ereignissen 
Daten von 9416 Frauen aus den Kontrollgruppen 
(Austrafien, Vofksrepubtik China, Kolumbien, ehe- 
~okratische Repubtik, Israel,. Philippinen und Thai- 
alen multizentrischen WHO-FalI-KontrolI-Studie zu 
?n. Positive Korrelationen mit I&nderspezifischen 
;phase(Median) (r >_ 0,95; p < 0;:005 ), das Alter bei der Meno- 
(r ~ 0,84) p < 0,025) und die Zeitspanne zvvischen Erstmenstrua- 
td Erstget~urf #>_ 0,59; p <: 0,22) (wenn die VR China nicht mit- 
i:~etWurde: r ~0.85, p< O.OY). Die Beziehung zwischen dem Alter 
~tqe~R o war schwach positiv im ndder Brustkfebsinzidenz 
tenSa (korrigiert fOrAIten r =.O, 18; p = 0,73), aber schwach 
15- bis 29-J~hrigen und der 30- bis v in don Altersgruppen der 
,rigen end schwach positiv in der Altersgruppe der 40- bis 49- 
mund der 50 c his 64-Jahricten. Eine starke inverse Korrelation 
(r <_-0,84; p < 0,03). Diese internationafen 6kologi- 
stimmen mit den Resultaten aus frQheren Studien 
~.n Oberein, wo Beziehungen zwischen h6herem 
jOngerem Alter bei der E~stmenstruation, ~lterern 
use, I&ngerer Dauer der reproduktiven Lebensphase 
curden. Im Gegensatz zu Studien, die indivi- 
korretiert das Alter bei der Erstgeburt nur 
#nzideilz in 6kologischen Studien. Dies deu- 
~riable unterschiedliche Konstrukte repr~sen- 
uf 6koloaischem oder individuellem Niveau 
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Appendix 
The data collection centers, and the principal investigator (PI), co-investigator (CI), and pathologist (P) at each 
participating center in alphabetical order by country, are as follows: 
University of Sydney, Department ofPublic Health, Sydney, Australia: Geoffrey Berry (PI), Robert MacLennan 
(CI), Rodney Shearman (CI), Tatiana Jelihovsky (P), Joan Cooper Booth (P). 
University of Chile, Faculty of Medicine, Hospital Jose Joaquin Aguirre, Department ofObstetrics and Gy- 
necology, and the Ministry of Health, Hospital Salvador, Department Obstetrics and Gynecology, Santiago, 
Chile: Ramiro Molina (PI), Luis Martinez (CI), Oriana Salas (CI), Alfredo Dabancens (P). 
Shanghai Institute of Planned Parenthood Research, Shanghai, China: Chen Zhiheng (PI), Tao Yun (CI), 
Hu Yong Wei (P). 
Hospital Universitario, WHO Collaborative Center for Research in Human Reproduction, Cali, Colombia: 
Alvaro Cuadros (PI), Nubia Aristizabal (P). 
Central Institute of Cancer Research , Academy of Sciences of the German Democratic Republic, Berlin, 
Germany: K. Ebeling (P), R Nishan (C), D. Kunde (P). 
Chiam Sheba Medical Center, Department of Clinical Epidemiology, Tel Hashomer, Israel: Baruch Modan 
(PI), Elaine Ron (CI), Esther Alfandary (CI). 
University ofNairobi, Nairobi Center for Research in Reproduction, Nairobi, Kenya: J.G. Mati (PI), Patrick 
Kenya (CI), Alfred Kungu (P), D. Gatei (P). 
Hospital General de Mexico, Mexico City: Hector Rodriguez Cuevas (PI), Socorro Benavides Salazar (CI), 
Antonio Palet (P), Patricia Ontiveros (P). 
University of the Philippines, College of Medicine, Manila, Philippines: Ruben A. Apelo (PI), Julietta R. de la 
Cruz (CI), Jose Baens (CI), Benita Javier (P). 
Chiang Mai University, Faculty of Medicine, Chiang Mai, Thailand: Suporn Silpisornkosol (PI), Tieng 
Pardthaisong (CI), Nimit Martin (CI), Choti Theetranont (P). 
Chulalongkorn University, Faculty of Medicine, Department of Obstetrics and Gynecology, WHO Col- 
laborating Centre for Research in Human Reproduction, Bangkok, Thailand: Banpot Boosiri (PI), Supawat 
Chutivongse (PI), Pramuan Virutamasen (CI), Chansuda Wongsrichanatai (CI), Prasarn Jimakorn (P). 
Mahidol University, Faculty of Medicine, Siriraj Hospital, Department ofObstetrics and Gynaecology, Family 
Planning Research Unit, Bangkok, Thailand: Suporn Koetsawang (PI) Daungdao Rachawat (CI), Nivat 
Chantarakul (P). 
University of Tromsf, Institute of Medical Biology, Tromsf, Norway: Helge Stalsberg (Reference Pathologist). 
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington, United 
States of America; Coordinating Center: David B. Thomas (Study Coordinator), Elizabeth A. Noonan. 
(Statistician). 
World Health Organisation, Olav Meirik, Timothy M.M. Farley, and Susan Holck, Special Programme of 
Research, Development and Research Training in Human Reproduction, Geneva, Switzerland. 
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